Call Today for a FREE Confidential Case Review
Toll-Free 24/7 (866) 920-0753

Invokana Bone Fracture Risk Warning Issued by FDA

Invokana Bone Fracture Risk Warning Issued by FDA

September 10, 2015 —The FDA has issued a Safety Communication to warn that the diabetes drugs Invokana and Invokamet may decrease bone density and increase the risk of bone fractures.

The Prescribing Information has always contained warnings about a possible risk of bone fractures, but the FDA is adding a new Warnings & Precaution to confirm that bone fractures are more common in patients on Invokana than a placebo.

According to the FDA:

“Fractures were observed as early as 12 weeks after treatment initiation, and were more likely to be low trauma (e.g., arising after falls from no more than standing height) and affect the upper extremities.”

The FDA has also added warnings about decreased bone mineral density after a 2-year study involving 714 elderly patients showed that Invokana caused more bone loss in the hip and spine than a placebo. Higher doses were linked to more bone loss.

The FDA has been investigating the link between Invokana and bone loss for years. In 2013, the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) warned (PDF) about higher rates of bone fractures observed during clinical trials. Those fractures primarily occurred in the spine and upper limbs with minor trauma.

Invokana belong to one of the newest class of diabetes drugs, SGLT2-inhibitors. The FDA is still evaluating the risk of bone fractures with other drugs in this class, including Farxiga, Xigduo XR, Jardiance, Gylxambi, and Synjardy.

This is also the second time the FDA has issued a warning for Invokana in 2015. In May, the agency issued a Safety Communication to warn about the risk of diabetic ketoacidosis, a life-threatening condition involving too much acid in the bloodstream.

Do I have an Invokana Lawsuit?

The Schmidt Firm, PLLC is currently accepting Invokana induced injury cases in all 50 states. If you or somebody you know has been injured, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.

Free Case Evaluation

The Schmidt Firm, PLLC has been recognized as one of the nation’s leading plaintiffs' law firms and handles cases in all 50 states. We are very proud of our legal achievements, but equally self-respecting of our firm's reputation for providing personal attention to each and every client we represent.

No matter what type of case you have, you may contact us with confidence by filling out the email contact form below or calling us directly by dialing toll free 24 hrs/day (866) 920-0753.